The current development of potent antifungal drugs necessitates reliable methods of in vitro susceptibility testing of clinical isolates. Other laboratories have noted with some antimicrobials that conventional tube dilution visual end points for determining minimal inhibitory concentrations (MIC) vary markedly with the inoculum. With seven isolates (four species) we compared the conventional method with one developed with a spectrophotometer. Yeasts were diluted to inocula of 102 to 103 cells/ml and incubated at 370C with 5-fluorocytosine or miconazole or without drug in a synthetic defined medium. At frequent intervals MICs were determined by the lowest drug concentration without visible turbidity. Concurrently, the percent transmission of each tube was measured and an inhibitory concentration (ICI,2) was calculated from the turbidimetric measurements. MICs of both drugs for all strains varied with the inoculum. Intrastrain differences averaged 128-fold for miconazole and greater than 8-fold with 5-fluorocytosine. This variability in MIC occurred when readings were made after 12 to 48 h of incubation. In contrast, IC12 values of all isolates varied less than twofold with the same range of inocula. Most isolates showed this independence when measured at 48 h. Fast-growing yeasts showed greater ICI02 variability unless the turbidimetric measurements were taken earlier while the drug-free growth was still in a rapid growth phase. This method is reproducible, inoculum independent, rapid, free from subjectivity and observer variability, and suitable for adaptation to a clinical setting.
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Fungal infections are an increasing problem with the growing use of immunosuppressive therapy, valve prostheses, and intravenous and urinary catheters and with the increased survival of patients with congenital and acquired immunodeficiencies (6, 9) . Potent antifungal agents, such as amphotericin B and 5-fluorocytosine (5-FC), are currently available, but their administration carries the risk of serious toxic reactions (2) . Newer agents are being developed, and they will require careful clinical evaluation. Reliable and practical in vitro sensitivity testing is necessary to select appropriate therapy.
There is no standardized method of testing the susceptibility of yeasts to antifungal agents. Most commonly, broth dilutions of the antifungal agent are performed. The lowest drug concentration that allows no visible growth of some inoculum is used as an end point (terined the minimal inhibitory concentration [MIC] ). This method has the advantage of simplicity and can be performed in any clinical laboratory. However, it is subject to observer variability. Furthermore, 5-FC MICs for cryptococci reportedly are influenced considerably by variations in the initial inoculum size (4). Inoculum size is not standardized between laboratories and often is not precisely standardized within the same laboratory (e.g., dilutions of an overnight broth culture).
We report here a method of susceptibility testing that employs turbidimetric techniques to measure growth inhibition. The lowest drug concentration that inhibits growth to a fraction of that in drug-free controls is deternined. This method has the advantage of objective measurement, thus minimizing observer variability. In addition, it appears free from inoculum-dependent variability.
MATERIALS AND METHODS
Seven yeasts were studied: Candida albicans (two strains), C. parapsilosis (three strains), C. tropicalis, and Torulopsis glabrata. All isolates were from clinical specimens, except the C. tropicalis (laboratory reference strain). The yeasts were identified as to species by current standard methods (10) over the inoculum range tested unless turbidimetric readings were taken earlier than 48 h.
The time period during which IC,/2 readings remained uniform was related to continued growth in the control tubes. Figure 5 demonstrates this relationship for one isolate whose growth in drug-free medium reached a "plateau" at 29%T (optical density, 0.53). The plateau is defined as the phase ofthe growth curve during which turbidity does not -further increase with continued observation. As can be seen from this example, the IC1/2 for various inocula showed no greater than twofold differences until the control tube approached the plateau. After a point, which could be defined as the lowest %T of control growth that gave an IC1/2 variation of no more than twofold over the range of inocula tested, the IC,/, values increased and showed more variation over this inoculum range. For this isolate, the point is 50%T. Figure 6 demonstrates "no growth." Neither variation between observers nor that which might occur between laboratories was examined in our studies, since all determinations were performed by the same investigator. However, variation would be expected to be maximal with an end point that attempted to distinguish "almost no growth" from "complete absence of growth." Second, the commonest criterion of no growth, no visible turbidity, assumes that very small changes in turbidity are always caused by cell growth. We also employed this criterion in the visual studies since it seemed the sharpest end point, but we are not convinced that the underlying assumption is always correct. In particular, suspensions that became minimally turbid during incubation with high concentrations of miconazole did not demonstrate significant increases in numbers of organisms (hemocytometer counts). It is possible that with some drugs and/or yeasts other events, such as increased adhesiveness with cell clumping or cell swelling (1), could account for minor changes in visual clarity independent of cell multiplication. It seems impossible to control for this with visual methods. A third drawback is inoculum dependence. Block et al. (4) , for example, demonstrated this for cryptococcus against 5-FC. We have demonstrated this for several species for both 5-FC and miconazole. To make visual methods reproducible one must be careful to standardize inocula. Because of different growth characteristics of various yeasts, the practice of using a standard dilution of an overnight growth would not be sufficient. Furthermore, our results suggest that in comparing the relative sensitivity of strains between different inocula, even if standardized, results can be conflicting. Thus in Fig. 1 The clinically important level of susceptibility is presently unknown. Turbidimetric methods will usually yield values below concurrent visual MICs although, as noted in Fig. 4 and 5, MICs with low initial inocula tend to approximate IC,,2 values. As one example, fungal meningitis can respond to therapy despite very low levels of antifungal activity in the cerebrospinal fluid, i.e., drug concentrations below the MIC for the organism as determined by the visual method (3, 5) . At present, it seems most important to utilize a method of susceptibility testing that is reliable, so that more firm correlations can be made with clinical efficacy.
